[Note that Mizuho is taking the plunge and starting Snap at Neutral. (lol)]
Via Bloomberg
- Adobe (ADBE) raised to buy at Wunderlich, PT $145
- Alarm.com (ALRM) raised to outperform at Imperial, PT $35
- Aqua America (WTR) raised to overweight at Barclays, PT $36
- B&G Foods (BGS) raised to outperform at Credit Suisse, PT $47
- Cabot Micro (CCMP) raised to buy at Aegis, PT $86
- Dean Foods (DF) raised to overweight at JPMorgan, PT $22
- Five9 (FIVN) raised to overweight at Pacific Crest, PT $22
- Gigamon (GIMO) raised to market outperform at JMP, PT $45
- L Brands (LB) raised to outperform at FBR, PT $60
- Numerex (NMRX) raised to equal-weight at First Analysis
- Texas Roadhouse (TXRH) raised to buy at BTIG, PT $50
- Vertex (VRTX) raised to market outperform at JMP, PT $115
- AXT (AXTI) cut to neutral at B Riley, PT $7
- Blue Buffalo (BUFF) cut to equal-weight at Morgan Stanley, PT $26
- Cervus Equipment (CERV CN) cut to market perform at Raymond James
- Cervus Equipment (CERV CN) cut to sector perform at RBC, PT C$14
- Exa (EXA) cut to hold at Canaccord, PT $15
- Franklin Resources (BEN) cut to underweight at Morgan Stanley
- Innocoll (INNL) cut to hold at Stifel, PT $2
- Lifetime Brands (LCUT) cut to neutral at Sidoti, PT $19
- Macerich (MAC) cut to sell at Goldman, PT $64
- Patheon NV (PTHN) cut to neutral at Baird, PT $28
- Patheon NV (PTHN) cut to sector weight at Keybanc
- SeaWorld (SEAS) cut to sell at Citi
- Simon Property (SPG) cut to neutral at Goldman, PT $185
- T. Rowe (TROW) cut to underweight at Morgan Stanley
- A-Mark Precious Metals (AMRK) resumed neutral at B Riley
- Adaptimmune (ADAP) rated new market perform at Wells Fargo
- Booz Allen (BAH) rated new buy at Vertical Research
- CACI (CACI) rated new buy at Vertical Research
- CSRA (CSRA) rated new hold at Vertical Research
- Cantel Medical (CMD) rated new market perform at Raymond James
- Ctrip.com (CTRP) rated new buy at First Shanghai, PT $59.28
- Engility Holdings (EGL) rated new hold at Vertical Research
- Entegris (ENTG) rated new buy at Aegis, PT $29
- Leidos (LDOS) rated new buy at Vertical Research
- Lion Biotech (LBIO) rated new outperform at Wells Fargo
- Netflix (NFLX) rated new outperform at Bernstein, PT $178
- Regeneron (REGN) rated new market perform at Oppenheimer
- SAIC (SAIC) rated new hold at Vertical Research
- Snap (SNAP) rated new neutral at Mizuho, PT $20
- Teladoc (TDOC) rated new outperform at Baird, PT $27
